Translational enhancement of mdm2 oncogene expression in human tumor cells containing a stabilized wild-type p53 protein.
about
MDMX regulation of p53 response to ribosomal stressEvidence for conservation and selection of upstream open reading frames suggests probable encoding of bioactive peptides.Dysregulated transcriptional and post-translational control of DNA methyltransferases in cancerRole of DNA repair machinery and p53 in the testicular germ cell cancer: a reviewRapamycin inhibits IGF-1-mediated up-regulation of MDM2 and sensitizes cancer cells to chemotherapyOrigin licensing and p53 status regulate Cdk2 activity during G(1).Mdm2: the ups and downs.The E7 oncoprotein of human papillomavirus type 16 stabilizes p53 through a mechanism independent of p19(ARF).The p53 tumor suppressor protein does not regulate expression of its own inhibitor, MDM2, except under conditions of stress.5'UTR variants of ribosomal protein S19 transcript determine translational efficiency: implications for Diamond-Blackfan anemia and tissue variability.New frontiers in translational control of the cancer genomeUpstream open reading frames as regulators of mRNA translation.Human papillomavirus oncoproteins E6 and E7 independently abrogate the mitotic spindle checkpoint.The functional TP53 rs1042522 and MDM4 rs4245739 genetic variants contribute to Non-Hodgkin lymphoma riskCoordination between cell cycle progression and cell fate decision by the p53 and E2F1 pathways in response to DNA damage.MDM2 promoter SNP344T>A (rs1196333) status does not affect cancer risk.The translational response of the human mdm2 gene in HEK293T cells exposed to rapamycin: a role for the 5'-UTRs.Translational control of cyclins.An essential role for the Saccharomyces cerevisiae DEAD-box helicase DHH1 in G1/S DNA-damage checkpoint recovery.The MDM2 gene amplification databaseAssociation of a genetic variation in a miR-191 binding site in MDM4 with risk of esophageal squamous cell carcinomaBugs as drugs for cancer.Global response of Saccharomyces cerevisiae to an alkylating agent.Stochastic modeling and simulation of the p53-MDM2/MDMX loopDesign, synthesis and initial biological evaluation of a novel pladienolide analog scaffold.MDM2 promoter SNP285 and SNP309; phylogeny and impact on cancer riskEffects of the MDM2 promoter SNP285 and SNP309 on Sp1 transcription factor binding and cancer risk.Induction of MDM2-P2 transcripts correlates with stabilized wild-type p53 in betel- and tobacco-related human oral cancer.Deregulation of the Rb and p53 pathways in uveal melanoma.MDM2 promoter polymorphism del1518 (rs3730485) and its impact on endometrial and ovarian cancer riskSplicing up mdm2 for cancer proteome diversity.Translational control in cancer etiology.Expression of a novel mRNA transcript for human microsomal epoxide hydrolase (EPHX1) is regulated by short open reading frames within its 5'-untranslated regionp53-independent mechanisms regulate the P2-MDM2 promoter in adult astrocytic tumoursP53 Is Involved in a Three-Dimensional Architecture-Mediated Decrease in Chemosensitivity in Colon Cancer.Expression of pAkt affects p53 codon 72 polymorphism-based prediction of response to radiotherapy in nasopharyngeal carcinoma.An siRNA screen for ATG protein depletion reveals the extent of the unconventional functions of the autophagy proteome in virus replication.Associations between the MDM2 promoter P1 polymorphism del1518 (rs3730485) and incidence of cancer of the breast, lung, colon and prostate.The associations between MDM4 gene polymorphisms and cancer riskMDM4 genetic variants and risk of gastric cancer in an Eastern Chinese population.
P2860
Q24316958-4B5E5DF6-CCDF-4221-80E6-27215CD23903Q25255689-2EB7A05C-B450-4753-8770-D299E8153470Q26827297-AA6DA24E-B27F-4ADD-8DE8-686EFE30B11BQ28069963-9AB6B1C3-0035-461E-B878-03DC66A5410DQ30419679-00F78883-B2CB-4780-A072-BDD0966856A6Q30434208-234AC365-F29A-47B9-AC5A-33E053214624Q33594040-91B78DF0-B4C2-4C5D-A2F3-BF69947C9556Q33650001-563EF53C-D896-49F2-9245-8C58080B13EAQ33786947-7DDE8B62-2D6C-4A6C-A498-5D614FE4588DQ33848953-995E01CC-13D1-4132-BFEA-D1C089B9819BQ33853235-C2ED1596-7E1E-45EF-8F55-3A24057997A1Q33966388-39CB8A01-9D60-4278-9EB4-7A9E5494A4B1Q34069364-9DE5F3FF-A298-43E5-BE42-523B1AA8D2DAQ34156039-49C1C18A-EE97-49E8-91E0-31197DDAC8FEQ34181478-FFA80336-1F3F-40FA-8F59-A0EAEEE122DFQ34257381-1192F8BF-ED4C-4531-A258-95B59CAE9D20Q34559580-A55E7E7B-3D5F-4109-ADED-CF46873E54EBQ34623222-4FB36974-9ECE-492F-9DC2-D53554F15606Q34644818-312D246A-B23C-43FD-839E-C0571FF3187EQ34672224-8BEA4B4A-DD88-40EA-BD22-FEF7B50149BFQ34749556-D10EF3E3-3D71-4914-B97F-29E1AD47B719Q34842154-F4D00508-130E-4AC7-8230-2B21CB2ACA45Q34994555-B62BFA8C-83F7-4111-993A-3B043F19C062Q35140857-481A7384-A071-401E-AAC2-49EE8DBC7C0CQ35209996-94328A60-950F-4CD7-9C9C-93C01F7E5C52Q35679374-3D711703-036D-4870-92F1-7E2E7EB5376CQ35693755-AB7A07DA-C799-4B03-BCEC-D4CB6841B1E2Q35745704-110EBBC7-BF75-488A-91DF-C7CBB51DA92EQ35829776-CFB89390-B9DF-4C76-B369-3B960650D574Q36270358-77F36388-F5E6-4066-87AA-A29A974663EAQ36387622-67BA87EF-ECA5-4772-B587-94EEA3FC0A75Q36555212-CCDB6514-3237-42AE-B69A-B4591DB7D24AQ36932875-B04443E8-3C54-4FF5-8C8E-E30C1559EF75Q36935974-22F872BE-D3E2-4E49-B135-BB8EEEC8B936Q37012038-B4FD841E-A37B-4147-9ECB-DD12A640AF36Q37037859-24EE135E-D93A-4E41-9EFB-DC72FB13BD36Q37216414-A227B756-D4E1-458D-8223-5AF2AC0883FDQ37317626-085283E8-937F-4D7D-BDCB-C986CFA40535Q37688285-431AD18C-BECC-4682-A729-914584C90680Q37746060-3024E667-DB13-4F76-B5DD-F2B51C4313F2
P2860
Translational enhancement of mdm2 oncogene expression in human tumor cells containing a stabilized wild-type p53 protein.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh-hant
name
Translational enhancement of m ...... bilized wild-type p53 protein.
@en
Translational enhancement of m ...... bilized wild-type p53 protein.
@nl
type
label
Translational enhancement of m ...... bilized wild-type p53 protein.
@en
Translational enhancement of m ...... bilized wild-type p53 protein.
@nl
prefLabel
Translational enhancement of m ...... bilized wild-type p53 protein.
@en
Translational enhancement of m ...... bilized wild-type p53 protein.
@nl
P2093
P1433
P1476
Translational enhancement of m ...... bilized wild-type p53 protein.
@en
P2093
D L George
J E Landers
S L Cassel
P304
P407
P577
1997-08-01T00:00:00Z